Volume 120, Issue 1 , Pages 144-149, July 2007
Exposure to dust mite allergen and endotoxin in early life and asthma and atopy in childhood
Background
There has been no longitudinal study of the relation between concurrent exposure to dust mite allergen and endotoxin in early life and asthma and atopy at school age.
Objectives
To examine the relation between exposure to dust mite allergen and endotoxin at age 2 to 3 months and asthma, wheeze, and atopy in high-risk children.
Methods
Birth cohort study of 440 children with parental history of atopy in the Boston metropolitan area.
Results
In multivariate analyses, early exposure to high levels of dust mite allergen (≥10 μg/g) was associated with increased risks of asthma at age 7 years (odds ratio [OR], 3.0; 95% CI, 1.1-7.9) and late-onset wheeze (OR, 5.0; 95% CI, 1.5-16.4). Exposure to endotoxin levels above the lowest quartile at age 2 to 3 months was associated with reduced odds of atopy at school age (OR, 0.5; 95% CI, 0.2-0.9). In contrast with its inverse association with atopy, endotoxin exposure in early life was associated with an increased risk of any wheeze between ages 1 and 7 years that did not change significantly with time (hazard ratio for each quartile increment in endotoxin levels, 1.23; 95% CI, 1.07-1.43).
Conclusion
Among children at risk of atopy, early exposure to high levels of dust mite allergen is associated with increased risks of asthma and late-onset wheeze. In these children, endotoxin exposure is associated with a reduced risk of atopy but an increased risk of wheeze.
Clinical implications
Early endotoxin exposure may be a protective factor against atopy but a risk factor for wheeze in high-risk children.
Key words: Endotoxin, dust mite, wheeze, atopy, asthma
Abbreviations used: EU, Endotoxin unit, OR, Odds ratio
Supported by grants AIEHS35786 and ES07036 from the National Institutes of Health to D.R.G. and D.K.M. J.C.C. is supported by grants HL04370, HL079966, and HL073373 from the National Institutes of Health.Disclosure of potential conflict of interest: D. R. Gold has lectured for Inbio. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(07)00629-X
doi:10.1016/j.jaci.2007.03.037
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 120, Issue 1 , Pages 144-149, July 2007
